Williams Jones Wealth Management, Llc. Genmab A/S Transaction History

Williams Jones Wealth Management, Llc.

$7.94 Billion
Q2 2024

A detailed history of Williams Jones Wealth Management, Llc. transactions in Genmab A/S stock. As of the latest transaction made, Williams Jones Wealth Management, Llc. holds 83,525 shares of GMAB stock, worth $1.93 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

83,525

Previous 89,435 6.61%

Holding current value

$1.93 Million

Previous $2.68 Million 21.57%

% of portfolio

0.03%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$25.13 - $30.27 $148,518 - $178,895	-5,910 Reduced 6.61%	83,525 $2.1 Million
Q1 2024 May 07, 2024	SELL	$26.43 - $32.77 $1.6 Million - $1.99 Million	-60,702 Reduced 40.43%	89,435 $2.68 Million
Q4 2023 Feb 14, 2024	SELL	$27.94 - $35.44 $206,923 - $262,468	-7,406 Reduced 4.7%	150,137 $4.78 Million
Q3 2023 Nov 14, 2023	SELL	$35.27 - $42.24 $74,067 - $88,704	-2,100 Reduced 1.32%	157,543 $5.56 Million
Q2 2023 Aug 14, 2023	SELL	$37.4 - $42.94 $91,929 - $105,546	-2,458 Reduced 1.52%	159,643 $6.07 Million
Q1 2023 May 15, 2023	SELL	$34.88 - $43.22 $377,471 - $467,726	-10,822 Reduced 6.26%	162,101 $6.12 Million
Q4 2022 Feb 14, 2023	BUY	$33.8 - $47.06 $42,182 - $58,730	1,248 Added 0.73%	172,923 $7.33 Million
Q3 2022 Nov 14, 2022	SELL	$31.52 - $373.61 $370,296 - $4.39 Million	-11,748 Reduced 6.4%	171,675 $5.52 Million
Q2 2022 Aug 15, 2022	SELL	$26.83 - $38.57 $1.93 Million - $2.78 Million	-72,034 Reduced 28.2%	183,423 $5.96 Million
Q1 2022 May 16, 2022	SELL	$30.95 - $39.68 $454,253 - $582,383	-14,677 Reduced 5.43%	255,457 $9.24 Million
Q4 2021 Feb 14, 2022	BUY	$35.87 - $47.12 $1.97 Million - $2.58 Million	54,847 Added 25.48%	270,134 $10.7 Million
Q3 2021 Nov 15, 2021	SELL	$41.55 - $48.72 $47,782 - $56,028	-1,150 Reduced 0.53%	215,287 $9.41 Million
Q2 2021 Aug 16, 2021	BUY	$32.88 - $44.57 $328,306 - $445,031	9,985 Added 4.84%	216,437 $8.84 Million
Q1 2021 May 17, 2021	BUY	$30.92 - $44.4 $645,362 - $926,716	20,872 Added 11.25%	206,452 $6.78 Million
Q4 2020 Feb 16, 2021	BUY	$33.66 - $40.76 $677,575 - $820,498	20,130 Added 12.17%	185,580 $7.55 Million
Q3 2020 Nov 13, 2020	BUY	$33.07 - $38.68 $946,628 - $1.11 Million	28,625 Added 20.92%	165,450 $6.06 Million
Q2 2020 Aug 14, 2020	BUY	$20.05 - $33.89 $303,757 - $513,433	15,150 Added 12.45%	136,825 $4.64 Million
Q1 2020 May 15, 2020	SELL	$17.15 - $25.22 $770,034 - $1.13 Million	-44,900 Reduced 26.95%	121,675 $2.58 Million
Q4 2019 Feb 14, 2020	SELL	$18.88 - $24.14 $20,768 - $26,554	-1,100 Reduced 0.66%	166,575 $3.72 Million
Q3 2019 Nov 14, 2019	BUY	$18.0 - $21.38 $3.02 Million - $3.58 Million	167,675 New	167,675 $3.4 Million

Others Institutions Holding GMAB

# of Institutions

235

Shares Held

48.7M

Call Options Held

6.8K

Put Options Held

27.6K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $15.2B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Williams Jones Wealth Management, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Williams Jones Wealth Management, Llc. with notifications on news.

Account

Williams Jones Wealth Management, Llc. Genmab A/S Transaction History